chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heart beats per minute go up to a 177 / Bounced my heart beat per minute very high; A. Fib. Symptoms; Having a real hard time understanding; I had sweats; This is a spontaneous report from a contactable consumer (patient). A 87-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on 06Oct2021 as dose 3, single for COVID-19 immunisation. The patient's medical history and the concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on an unknown date as dose 1, single for COVID-19 immunisation and received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot number was not reported), via an unspecified route of administration on an unknown date as dose 2, single for COVID-19 immunisation. On an unknown date in Oct2021, the patient's heart beats per minute go up to a 177 and had sweats and with this AFib (atrial fibrillation) symptoms. In Oct2021, the patient had not had other symptoms like left arm pain or chest heaviness, but it had bounced the patient's heartbeat per minute, very high. It was really doing a number on patient's heart beats per minute. The patient couldn't understand and had a real hard time understanding. The patient underwent lab tests and procedures which included heart rate: 177 in Oct2021, heart rate: high on Oct2021 and bounced heartbeat per minute very high. The outcome was unknown for the reported events.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Information has been received from a RN concerning a 9 year old female pt with no allergies and no past medical history who on 19Jul1995 was vaccinated in the left leg with first dose of varicella virus vaccine live. Concomitant vaccination on 19Jul95 included a first dose in the right leg of Hib conj vaccine (PROHIBIT). There was no illness at the time of vaccination. On 19Jul95, a tuberculin purified protein derivative was place and had a negative result. On 26Dec03, the pt was evaluated by a physician and had multiple vesicles and papules on her trunk, back and scalp. The pt recovered seven days after the outbreak. No other laboratory tests were performed. Additional information is not expected.
Dizziness; throwing up; fatigued; This is a spontaneous report from a contactable consumer. A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EN6201, Expiration Date: not reported) via an unspecified route of administration on 25Feb2021 (at the age of 54 years old) as dose 1, single for COVID-19 immunisation. Medical history included menopause from an unknown date. Concomitant medications included vitamins taken for an unspecified indication and unspecified drug taken for menopause - both start and stop date were not reported. On an unspecified date, the patient experienced dizziness, was throwing up and was fatigued. No treatment was received for the adverse events. The reporter was asking if this was normal. Outcome of all events was unknown.  No follow-up attempts are possible. No further information is expected.
C/o development of non pruritic rash 10 days following MMR vaccine - preceded by one day of catarrhal sxs. (no fever). Rash duration: 5 days; all symptoms resolved without treatment by 5-7 days.
Shingrix vaccine was reconstituted with sterile water for injections diluent (used for Merck live vaccines such as Zostavax) instead of the diluent provided in the Shingrix box. Patient has not experienced any adverse effects. Patients will return for a correctly reconstituted vaccination.
5 minutes after receiving his dose patient became dizzy, syncopal, nauseous, diaphetic, pale. He laid down on the carpet by his chair.  BP was 90/60 Hr 60's. Blood sugar by fingerstick was 114. Given some juice to drink and attempted after several minutes to sit which failed 3 times and symptoms reoccurred. BP was 87/63 Hr 67 on second check. He was unable to tolerate standing after 30 minute so was advised and agreed to go to ED by EMS. He was transported there at 1015 am.
Patient had a tonic clonic seizure during the night after receiving his immunizations. It self resolved. He has no history of seizure. He went via EMS to the ER where he had a normal work up.
had a bad sore throat w/swelling of lt side of face seen by MD given Augmentin;
104 degree fever; chills; body soreness; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 23Mar2021 at 13:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient was allergic to penicillin. The patient did not receive concomitant medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Mar2021 at 01:45, the patient experienced 104-degree fever, chills, body soreness, and fatigue. The adverse events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The patient did not receive treatment for the reported events 104-degree fever, chills, body soreness, and fatigue. The clinical outcomes of the events 104-degree fever, chills, body soreness, and fatigue were recovered with sequelae (reported as recovered with lasting effects) on an unknown date in Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
GUILLAIN-BARRE SYNDROME; This spontaneous report received from a consumer via (social media) a company representative concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) 1 total dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  Since MAY-2021, the patient was paralyzed from Guillain-barre syndrome from the waist down. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from Guillain-barre syndrome. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210854750-covid-19 vaccine ad26.cov2.s-Guillain-Barre syndrome. This event(s) is labeled per RSI and is therefore considered potentially related.
[Moderna COVID-19 mRNA Vaccine] treatment under Emergency Use Authorization(EUA): Patient received Moderna COVID-19 vaccine on 1/23/201. It was determined after her received this that he had received Bamlanivimab monoclonal antibody therapy on 12/24/2020. Patient has had not adverse reactions after receiving the vaccine. His second dose of the Moderna vaccine will be deferred until early April (90 days after receiving Bam therapy).
Heightened depression, bad judgment, difficulty performing regular familiar tasks, mild neuropathy, disoriented, memory loss, loss of various cognitive skills.
Patient stated she had significant swelling and redness lasting 2-3 weeks on whole upper part of arm, including lymph nodes under arms.
rashes devel next day p/receiving vax on face, around eyelids, & on neck & arms; rashes seen more on face & around eyelids;
wasn't able to stay awake, that she was tired all the time/really tired all the time and really cranky tired; aching; irritable; it is affecting her work; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Jan2022 (Lot number: FJ1614) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset 2022, outcome "unknown", described as "wasn't able to stay awake, that she was tired all the time/really tired all the time and really cranky tired"; PAIN (non-serious) with onset 2022, outcome "unknown", described as "aching"; IRRITABILITY (non-serious) with onset 2022, outcome "unknown", described as "irritable"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 2022, outcome "unknown", described as "it is affecting her work".  Additional information: Reporter states she was calling about the Pfizer Vaccine and was really tired all the time and really cranky tired and just got the vaccine a week ago and couldn't even stay awake on the job and has an evening job and it is affecting her work.  No follow-up attempts are possible. No further information is expected.
Received first dose of vaccine on 12/28/2020, returned to vaccination clinic on 1/8 for second dose and vaccinator gave second dose of vaccine too early (10 days early). Vaccinator counseled. Patient observed and no reported adverse reactions.
KINRIX given instead of PEDIARIX. DOH was contacted and explained that immunization will count as long as timing is correct, and it is.
she went to receive her 2nd vaccine dose and the head person at the vaccination site said they would not vaccinate me without clearance from an allergist due to her reactions following her first Pfizer vaccine dose; rashes on my legs; malaise; fatigue; diarrhea; This is a spontaneous report from a contactable consumer. This female consumer reported that a female patient with unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not provided), dose 1 via an unspecified route of administration on 03Feb2021 as DOSE 1, SINGLE for covid-19 immunisation. Patient's medical history and concomitant medications were not reported. Consumer states she reported her side effects. She received first Pfizer vaccine one month ago, 03Feb2021 and 30 hours later developed rashes on my legs every evening x 3-4 times. Consumer also states she experienced malaise, fatigue and diarrhea. Consumer states she went to receive her second vaccine dose and the head person at the vaccination site said they would not vaccinate me without clearance from an allergist due to her reactions following her first Pfizer vaccine dose. She questioned if other people had rashes too after being vaccinated. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided   This case was linked to MOD-2021-395985 (Patient Link).
no illness or ADRs on that day, but patient only received 1st dose of his primary series of COVID-19 Vaccine (pfizer). then was given the bivalent new omicron dose. Pt never received the the second dose of his primary series
I received the second dose of the Moderna COVID-19 vaccine on 3/1/2021. On 8/12/2021, I began sneezing a lot. This lasted for about a day or two, and then it was over. I went to the doctor's office to undergo a COVID-19 rapid test, and the result was positive. After that, I just went home and self-isolated for about 10 days.
She has tingling and numbness in fingers of both hands.; She has tingling and numbness in fingers of both hands.; Stiffness in both hands; 2-3 days later(after 2nd dose), she started getting muscle and joint aches all over her body.; 2-3 days later(after 2nd dose), she started getting muscle and joint aches all over her body.; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (She has tingling and numbness in fingers of both hands.), HYPOAESTHESIA (She has tingling and numbness in fingers of both hands.), MUSCULOSKELETAL STIFFNESS (Stiffness in both hands), MYALGIA (2-3 days later(after 2nd dose), she started getting muscle and joint aches all over her body.) and ARTHRALGIA (2-3 days later(after 2nd dose), she started getting muscle and joint aches all over her body.) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 027B21A) for COVID-19 vaccination.     Concurrent medical conditions included Glaucoma (Eye drops for glaucoma.). Concomitant products included ESTROGENS CONJUGATED (PREMARIN) for an unknown indication.   On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Sep-2021, the patient experienced MYALGIA (2-3 days later(after 2nd dose), she started getting muscle and joint aches all over her body.) and ARTHRALGIA (2-3 days later(after 2nd dose), she started getting muscle and joint aches all over her body.). On an unknown date, the patient experienced PARAESTHESIA (She has tingling and numbness in fingers of both hands.), HYPOAESTHESIA (She has tingling and numbness in fingers of both hands.) and MUSCULOSKELETAL STIFFNESS (Stiffness in both hands). The patient was treated with IBUPROFEN for Adverse reaction, at an unspecified dose and frequency and PREDNISONE for Adverse reaction, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (She has tingling and numbness in fingers of both hands.), HYPOAESTHESIA (She has tingling and numbness in fingers of both hands.), MUSCULOSKELETAL STIFFNESS (Stiffness in both hands), MYALGIA (2-3 days later(after 2nd dose), she started getting muscle and joint aches all over her body.) and ARTHRALGIA (2-3 days later(after 2nd dose), she started getting muscle and joint aches all over her body.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications includes Eye drops for glaucoma.   Most recent FOLLOW-UP information incorporated above includes: On 11-Sep-2021: Added treatment medication (Prednisone) and new event (Stiffness in both hands).
One hour after injection redness severe inflammation pain hot to touch - treated with cold ice pack (no towel) - broke out with blisters after applying ice pack - went to ER applied bacitracin ointment - followup with M.D. - burst blisters - treated for 3d degree burn with burn ointment and wound care - took pictures thru process
I received the Covid 19 vaccination at 3:00 pm on 12/18 no trouble went home. Upon going to sleep the left arm was numb thought and got up to use the bathroom had diarrhea. While in the restroom hit face had a Syncope episode regain  conscience went to ER had 4 stitches in chin. Since 12/20 felt fine and was able to return to work.
4 hours after vaccine, sore arm, fatigue, headache, blurred vision 12 hours after vaccine, full body tremors, fever of 102, extreme muscle weakness, fatigue, deep chest cough, shortness of breath. fatigue, weakness and cough continued for three days after  vaccine before subsiding
Felt like he was hit by a truck; vaccination site pain; Aches all over the body; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt like he was hit by a truck), VACCINATION SITE PAIN (vaccination site pain) and MYALGIA (Aches all over the body) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (March 2020). Concomitant products included METOPROLOL for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION COMPLICATION (Felt like he was hit by a truck), VACCINATION SITE PAIN (vaccination site pain) and MYALGIA (Aches all over the body). On 14-Jan-2021, VACCINATION SITE PAIN (vaccination site pain) had resolved. At the time of the report, VACCINATION COMPLICATION (Felt like he was hit by a truck) and MYALGIA (Aches all over the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Product storage error; patients who received expired doses of the Moderna COVID vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients who received expired doses of the Moderna COVID vaccine) and PRODUCT STORAGE ERROR (Product storage error) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 068H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients who received expired doses of the Moderna COVID vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients who received expired doses of the Moderna COVID vaccine) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided. On 13-Jan-2022 vial was initially stored in the refrigerator. Vial expired on 12-Feb-2022 and administered to patients on 17-Feb-2022. Treatment information was not provided.
Discomfort; The shot and follow-up worth every ache; This case was reported by a consumer via interactive digital media and described the occurrence of injection site discomfort in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced injection site discomfort and pain. On an unknown date, the outcome of the injection site discomfort and pain were unknown.   It was unknown if the reporter considered the injection site discomfort and pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 17-Oct-2022 Reporter's Comment:  This case was reported by a patient via interactive digital media. The patient received the shingles shot. The patient experienced discomfort around the shot that was nothing to the misery that was shingles.  The shot and the follow up was much milder and worth every ache. Additional Supportive Information: The follow up would not possible, as no contact, details were available.
body aches, headaches different than regular migraines that would come on without warning, nausea, fatigue,
My daughter started crying and appeared to be very uncomfortable. Her body was very tense and she appeared to be writhing in pain. She continued like this for approximately 4 hours. She was inconsolable and refused to nurse (this was the only time in her life that this had every occurred). Eventually, after screaming and crying for several hours, she fell asleep. For the remainder of the day, when awake, she was very agitated.
Severe redness, swelling, heat, itching and pain at injection site and surrounding tissue; approximately 4" wide x 5" long; onset 1-15-2021. Began treatment with topical muciprocin 6 days ago and symptoms are improving.
1 of 4 pts vaxed 9NOV94;pt exp edema from shoulder to elbow;event appeared to be cellulitis;unk if culture was taken;ATB prescribed;pt recovered;
CLIENT HURT HER ANKLE COMING OUT OF HER BED ON 4/10/21 AND DEVELOPED A BIG BRUISE, SWELLING, AND COOL TO TOUCH THAT DIDN'T HEAL AND REQUIRED A UREGENT CARE VISIT ON 4/21/21.  SYMPTOMS HAVE STAYED THE SAME , NOT PROGRESSIVELY GETTING WORSE.  CLIENT WENT TO SEE HER PRIMARY AND HE SAID IT WAS 'ANGRY' AND NEEDED A VISIT TO URGENT CARE FOR AN ULTRASOUND TO RULE OUT A BLOOD CLOT.
1" diameter red, hard, mass lt upper leg 11 days p/vax per grandma hard mass involved most of upper leg rt p/shot;
Temp 104+ chills, fever, (too sick to take again). BP 225/125 sweating, vomiting. HR 115 severe pain (even my fingernails hurt!) extreme fatigue, rash felt I was dying (I was alone).
12/28/2021: Event occurred after 2nd vaccine.  Patient had a syncopal event during his hemodialysis session early today.  Patient tested positive for Covid-19 in current admission.  Hx of COPD, CAD, post CABG.  COPD on 2 to 3 L of oxygen at home, Denies any fever, chills, nausea, vomiting or diarrhea. During evaluation of the patient, he got short of breath and was experiecing increase work of breathing through purse lips. Patient having moderate chest pain. He had an episode of vomiting. Nitro did not improved the chest pain. He was placed on a non rebreather mask and received breathing treatments which mildly improved his respiratory distress and his chest pain.
Full body pain starting in my lower back. Vaccine given at approx 1100AM, back pain started about 1800. Pain radiated to abdomen, upper back, legs, and head by 2000. Nonstop shivering and chills from 2000 throughout the night. Fever of 102.6°. Fever broke at about 0200 on 12/15/2021 and I began sweating profusely. Worst headache of my life started at this time; 10/10 pain. 1500mg Tylenol and 600mg Advil taken between midnight and 0300 to no avail. Generalized malaise remained throughout 12/15/2021. Symptoms subsided by following day, 12/16/2021
On the day of the vaccine, I had pain in my arm where I got the shot hours later.  I had a bit of a fever and chills that night.  The next day I began to get bumps on the arm that I got the shot at around 2:00 pm. I took an allergy antihistamine pill and it went away for a couple of hours. Later at night, I noticed small bumps and went to sleep. I woke up at around 6:00 am (2 days after getting the vaccine) and noticed I got hives all over my arms and legs. I went to urgent care and they said I should just continue using the antihistamines. I did and it has been two weeks since the vaccine and every day I still get hives. Not one day has passed where I have not gotten an allergic reaction with hives.
Patient was fussy in the afternoon (received shots in AM) with two periods of 30 seconds each of stiffening and shaking of the whole body while crying. Since that day, she has had an increased startle reflex - Starting frequently. MOC very worried. Exam unremarkable.
Extreme pain in the shoulder area all the way to the left hand for several days. Pain didn't subside until strong painkiller prescription medication was ingested. Even after 2 weeks and daily dose of painkillers, I am still not able to lift my left arm (where I got the flu shot) fully.